Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 235

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 235
---
 to any comments made by the Purchaser and its outside legal counsel, and agrees that all information relating to the Purchaser that is furnished in writing by or on behalf of the                                                         
 Purchaser for inclusion in the Circular or other related documents must be in a form and content satisfactory to the Purchaser, acting reasonably. The Company shall provide the Purchaser with a final copy of the Circular prior to its mailing to the 
 Shareholders.                                                                                                                                                                                                                                            |

| (f) | The Purchaser shall provide, in a reasonably timely and expeditious manner, in writing to the Company, the                                                                                                                                      
 Purchaser Information, as applicable, that is required by the Interim Order or Law to be included by the Company in the Circular or other related documents. The Purchaser shall ensure that the Purchaser Information (i) complies in material 
 respects with the Interim Order and Law and (ii) does not contain any Misrepresentation.                                                                                                                                                        |

| (g) | The Company shall not be responsible for any information in the Circular relating solely to the Purchaser and                                                                                                                                             
 its affiliates, nor shall it be responsible or liable for any Misrepresentation or alleged Misrepresentation in any information included in the Circular solely in respect of the information furnished to the Company in writing by the Purchaser or its 
 legal counsel for inclusion in the Circular.                                                                                                                                                                                                              |

| (h) | Each Party shall promptly notify the other Party if it becomes aware that the Circular contains a                                                                                                                                                  
 Misrepresentation, or otherwise requires an amendment or supplement (including with respect to the Meeting). The Parties shall cooperate in the preparation of any such amendment or supplement as required or appropriate, and the Company shall  
 promptly mail, file or otherwise publicly disseminate any such amendment or supplement to the Shareholders in and to all jurisdictions where such amendments or supplements are required to be mailed, complying in all material respects with all 
 applicable Laws on the date of the mailing thereof and, if required by the Court or by Law, file the same with the Securities Authorities or any other Governmental Entity as required.                                                            |

| (i) | The Company shall promptly notify the Purchaser upon the receipt of any correspondence with respect to the                                                                                                                                                
 Circular or the Arrangement, whether written or oral, from any Securities Authority or the staff of a Securities Authority with respect to the Circular or the Arrangement or any request from any Securities Authority or the staff of a Securities      
 Authority for information related to the Circular or the Arrangement or amendments or supplements to the Circular, and shall promptly provide